Jp. Malhaire et al., PREOPERATIVE CONCOMITANT RADIOCHEMOTHERAPY IN SQUAMOUS-CELL CARCINOMAOF THE ESOPHAGUS - RESULTS OF A STUDY OF 56 PATIENTS, International journal of radiation oncology, biology, physics, 34(2), 1996, pp. 429-437
Citations number
52
Categorie Soggetti
Oncology,"Radiology,Nuclear Medicine & Medical Imaging
Purpose: Today the prognosis for patients with esophageal carcinoma st
ill remains quite poor. In the last few years interesting results have
been obtained by associating radio- and chemotherapy with or without
surgery with this type of cancer. In this work we report the results o
f concomitant radio- and chemotherapy in a split-course schedule prece
eding surgery for the treatment of squamous cell carcinomas of the eso
phagus. Methods and Materials: Fifty-six patients with squamous cell c
arcinomas of the esophagus were treated between April 1989 and Septemb
er 1993 in the Centre Hospitalier Universitaire in Brest, France with
two courses of preoperative concomitant radiochemotherapy, separated b
y a 2-week interval, and followed by surgery (each course 18.5 Gy in f
ive fractions, days 1-5 with continuous infusion 5-fluorouracil (5-FU)
800 mg/m(2) days 1-5 and cisplatinum 70 mg/m(2) day 2). Patients who
had responded well to preoperative treatment (response > 50%) received
four more courses of chemotherapy alone, The two patients who were no
t operated and those with palliative surgery received a third course o
f radiochemotherapy (radiotherapy 12 Gy in five fractions, days 1-5).
Results: Fifty-four patients were operated on, Twenty-one showed histo
logical complete response at surgery (37.5% of the whole group). Actua
rial survival for the 56 patients was 55% at 3 years and 30% at 4 year
s, with a median survival of 37.4 months (40.4 months for complete res
ponders to preoperative treatment). Toxicity of preoperative concomita
nt radio-chemotherapy was low (5-FU had to be stopped in one patient b
ecause of cardiac rythm disturbances and in another patient because of
aplasia Grade 4 associated with infection after the first course). Po
stoperative mortality was 11% (six patients). Conclusion: This combina
tion of preoperative radiochemotherapy followed by surgery seems to im
prove both response rates and survival in patients with esophageal can
cer when compared with previous patients treated with surgery alone in
our hospital or with results found in literature and it warrants furt
her studies.